Key Drivers
- Margin Improvement
- Debt Reduction
- Liquidity Pressure
AIAI Summary
ASTH's upside now hinges on proving that its $120.4M of gross shared savings converts into durable retained margins and free cash flow, which could accelerate deleveraging and justify its premium valuation; until disclosure improves, thin margins and nearly $1B of debt make the $34.30 support level a key risk marker.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Improvement
- •Debt Reduction
- •Liquidity Pressure
ASTH's Q2 execution and debt repayment improved cash flow and margins, but thin profitability, high leverage, weakening liquidity, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Bearish trend
- •Critical support
- •Rebound trigger
ASTH is bearish over the last month, with $34.30–$34.50 support critical; a break lower signals further downside, while reclaiming $37.60–$38.10 could spark a rebound.
Declined from the high-$38 area to $34.36 over the last month
Sentiment & News
Similar Companies in Healthcare
Other companies in the same sector with AI ratings